Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses

Cancer Cell(2022)10.1016/j.ccell.2022.05.013Source: DataRank Database

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0. It has been cited 46 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access46 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 4.35)OA: bronzeTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Justin Kim ORCID,David Qualls ORCID,Madeline A. Hwee,Ya-Hui Lin ORCID,Sawsan R. Boutemine

Live enrichment

PubMed:35679859 PMC:PMC9149241 OpenAlex:https://openalex.org/W4281737237

National Institutes of Health

Grant: CA230157

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: K08 CA230157

NCI NIH HHS

Grant: U01 CA228963

National Institutes of Health

Grant: 1K08CA230157-01A1

Role of tumor burden in limiting durable reinvigoration by PD-1 blockade

Pershing Square Sohn Cancer Research Alliance

Conrad N. Hilton Foundation

University of Pennsylvania

Parker Institute for Cancer Immunotherapy

FWCI

4.35

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1535610822002264/pdf

publisherhttp://www.cell.com/article/S1535610822002264/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610822002264?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610822002264?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2022.05.013

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations0301 basic medicine0303 health sciences03 medical and health sciencesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCOVID-19HumansImmunity, CellularImmunity, HumoralImmunologic MemoryReceptors, Antigen, T-CellSARS-CoV-2

MeSH Terms

COVID-19SARS-CoV-2HumansImmunity, CellularImmunologic MemoryReceptors, Antigen, T-CellCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesImmunity, Humoral

Keywords

Coronavirus disease 2019 (COVID-19)ImmunologyImmunityHumoral immunityCD82019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cellular immunityBiologyCell mediated immunityCytotoxic T cellVirologyImmune systemMedicineDiseaseGeneticsInternal medicineInfectious disease (medical specialty)CancerCD20T cellRituximabConvalescentCovid-19Sars-cov-2CD4-Positive T-LymphocytesImmunity, CellularReceptors, Antigen, T-CellCD8-Positive T-LymphocytesArticleImmunity, HumoralHumansImmunologic Memory

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (2)

Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy

N/A

0.926DataRank · unranked

Cell Reports Medicine(2022)

co-cited

10.1016/j.xcrm.2022.100811

Analyzing real-time PCR data by the comparative CT method

N/A

1.5DataRank · unranked

Nature Protocols(2008)

co-cited

10.1038/nprot.2008.73

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses

FAIR Checklist

Authors (20)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (2)